OTCPK:SSMX.F

Stock Analysis Report

Executive Summary

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis.

Snowflake

Fundamentals

Flawless balance sheet second-rate dividend payer.


Similar Companies

Share Price & News

How has Sysmex's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.5%

SSMX.F

1.1%

US Medical Equipment

-0.6%

US Market


1 Year Return

-23.9%

SSMX.F

9.9%

US Medical Equipment

0.6%

US Market

SSMX.F underperformed the Medical Equipment industry which returned 9.5% over the past year.

SSMX.F underperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

SSMX.FIndustryMarket
7 Day3.5%1.1%-0.6%
30 Day-4.2%0.6%2.2%
90 Dayn/a2.9%1.1%
1 Year-23.9%-23.9%10.8%9.9%2.9%0.6%
3 Year-10.9%-10.9%70.1%64.9%44.6%35.2%
5 Year69.4%69.4%138.9%111.8%61.9%44.2%

Price Volatility Vs. Market

How volatile is Sysmex's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Sysmex undervalued based on future cash flows and its price relative to the stock market?

39.54x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Sysmex's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Sysmex's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Sysmex is good value based on earnings compared to the US Medical Equipment industry average.

Sysmex is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Sysmex is poor value based on expected growth next year.


Price Based on Value of Assets

Sysmex is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Sysmex expected to perform in the next 1 to 3 years based on estimates from 13 analysts?

10.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Sysmex's revenue is expected to grow by 7.9% yearly, however this is not considered high growth (20% yearly).

Sysmex's earnings are expected to grow by 10.3% yearly, however this is not considered high growth (20% yearly).

Sysmex's revenue growth is expected to exceed the United States of America market average.

Sysmex's earnings growth is positive but not above the United States of America market average.

Sysmex's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Sysmex is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Sysmex performed over the past 5 years?

9.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Sysmex's year on year earnings growth rate has been positive over the past 5 years.

Sysmex's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Sysmex's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.


Return on Equity

Sysmex has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Sysmex used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Sysmex's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Sysmex's financial position?


Financial Position Analysis

Sysmex is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Sysmex's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Sysmex has no debt.

Sysmex currently has no debt however we can't compare to 5 years ago as we have no data for that period.

Sysmex has no debt, it does not need to be covered by operating cash flow.

Sysmex has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

Sysmex has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is Sysmex's current dividend yield, its reliability and sustainability?

1.06%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Sysmex's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

Sysmex's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (2.6x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Sysmex's salary, the management and board of directors tenure and is there insider trading?

2.4yrs

Average management tenure


CEO

Hisashi Ietsugu 0

23.3yrs

Tenure

JP¥203,000,000

Compensation

Mr. Hisashi Ietsugu has been the Chairman of the Managing Board at Sysmex Corporation (a holding company of Sysmex America Inc.) at Sysmex India Pvt. Ltd. since April 2013 and its Chief Executive Officer a ...


CEO Compensation Analysis

Hisashi's remuneration is lower than average for companies of similar size in United States of America.

Hisashi's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.4yrs

Average Tenure

The tenure for the Sysmex management team is about average.


Board Age and Tenure

6.4yrs

Average Tenure

The tenure for the Sysmex board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Kaoru Asano (74yo)

    CTO, COO LS Business Unit

    • Tenure: 5.3yrs
  • Yukio Nakajima

    Senior Exec. Officer

    • Tenure: 20.3yrs
  • Hisashi Ietsugu

    Chairman of the Managing Board

    • Tenure: 23.3yrs
    • Compensation: JP¥203.00m
  • Frank Buescher

    Executive Officer

    • Tenure: 0yrs
  • Yukio Hamaguchi

    Senior Executive Officer

    • Tenure: 0.7yrs
  • Junzo Yamamoto

    Senior Executive Officer

    • Tenure: 2.3yrs
  • Iwane Matsui

    Senior Executive Officer & MD

    • Tenure: 2.4yrs
  • Kenji Tachibana

    Senior Executive Officer

    • Tenure: 5.3yrs
  • Ikuo Otani

    Senior Executive Officer

    • Tenure: 0.7yrs
  • Hiroshi Kanda

    Senior Executive Officer & MD

    • Tenure: 2.4yrs

Board Members

  • Kaoru Asano (74yo)

    CTO, COO LS Business Unit

    • Tenure: 5.3yrs
  • Yukio Nakajima

    Senior Exec. Officer

    • Tenure: 20.3yrs
  • Hisashi Ietsugu

    Chairman of the Managing Board

    • Tenure: 23.3yrs
    • Compensation: JP¥203.00m
  • Kazuya Obe

    Member of the Managing Board

    • Tenure: 10.3yrs
  • Mitsuru Watanabe (68yo)

    Member of the Managing Board

    • Tenure: 10.3yrs
  • Junzo Yamamoto

    Senior Executive Officer

    • Tenure: 2.3yrs
  • Kenji Tachibana

    Senior Executive Officer

    • Tenure: 5.3yrs
  • Yukitoshi Kamao

    Member of the Managing Board

    • Tenure: 0yrs
  • Susumu Nishiura

    Outside Member of the Managing Board

    • Tenure: 21.3yrs
  • Koichi Onishi

    Outside Member of the Managing Board

    • Tenure: 3.3yrs

Company Information

Sysmex Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sysmex Corporation
  • Ticker: SSMX.F
  • Exchange: OTCPK
  • Founded: 1968
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: JP¥1.523t
  • Listing Market Cap: JP¥14.108b
  • Shares outstanding: 208.74m
  • Website: https://www.sysmex.co.jp

Number of Employees


Location

  • Sysmex Corporation
  • 1-5-1, Wakinohama-Kaigandori
  • Chuo-ku
  • Kobe
  • Hyogo
  • 651-0073
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SSMX.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 1995
6869TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYNov 1995
0YXDB (Deutsche Boerse AG)YesCommon StockDEEURNov 1995
SSMX.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDApr 2011

Biography

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, uri ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 23:50
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.